In order to determine the role of GIPR in CFA-induced chronic pain and anxiety-like behaviors, GIPR agonist D-Ala2-GIP was injected intraperitoneally (i.p.)at a dose of 25 nM/kg, once daily for 10 days. The gene discussed is GIPR; the disease is Anxiety.